ORIGINAL RESEARCH article
Front. Oncol.
Sec. Pediatric Oncology
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1551799
This article is part of the Research TopicEmerging Strategies in Pediatric Hepatoblastoma Care: A Multidisciplinary ApproachView all 3 articles
Clinical Comparison of Radiofrequency Ablation and Surgical Resection in Treating Pulmonar Metastasis of Hepatoblastoma
Provisionally accepted
- 1Qilu Hospital of Shandong University (Qingdao), Qingdao, China
- 2Affiliated Cancer Hospital of Shandong First Medical University, Jinan, China
- 3The Third Affiliated Hospital of Shandong First Medical University, Jinan, China
- 4Shandong First Medical University, Jinan, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: To explore the efficacy variances between radiofrequency ablation and traditional surgical resection in treating pulmonary metastasis of hepatoblastoma in children, and to provide more feasible methods for the treatment of this disease. Methods: A total of 91 pediatric hepatoblastoma (HB) patients with pulmonary metastases, admitted to Shandong Cancer Hospital between Sept. 2021 and Oct. 2023, were enrolled in this study. Among them, 31 received radiofrequency ablation for pulmonary metastasis eradication, while 60 underwent surgical resection to remove the pulmonary metastases. To assess the comparative effectiveness of these two interventional approaches in treating pediatric pulmonary metastases from hepatoblastoma, differences between the two groups were analyzed in terms of alpha-fetoprotein (AFP) levels, complication rates, antibiotic use, operative duration, length of hospital stay, and hospitalization costs. Results: The average levels of AFP in both the radiofrequency ablation group and the surgical resection group decreased significantly after treatment, with no statistical significance between the groups (P>0.05). The incidences of pneumonia, pulmonary atelectasis, and pneumothorax were statistically different between the groups (P<0.05). Antibiotic use was markedly lower in the radiofrequency ablation group (c2=43.4291, P<0.001) as was the usage of advanced antibiotics (c2=56.3477, P<0.001) compared to the surgical group. Additionally, both the operation time (t=11.186, P<0.001) and hospitalization duration (t=6.064, P<0.001) were significantly shorter in the radiofrequency ablation group. The treatment costs for the radiofrequency ablation group were also significantly lower than those for the surgical group (t=3.092, P=0.003). Conclusion: Radiofrequency ablation for HB pulmonary metastases is more feasible, safer, and cost-effective due to its advantages of less invasive and painful, faster recovery, economical, and lower adjacent complication rate.
Keywords: Radiofrequency ablation, surgical resection, Hepatoblastoma, Pulmonary metastasis, Children
Received: 26 Dec 2024; Accepted: 21 Oct 2025.
Copyright: © 2025 Niu, Li, Xu, Wang, Wang, Liu and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Hongxin Niu, sdblache@126.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.